IRIS
CRISCUOLO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.655
AS - Asia 1.293
NA - Nord America 1.263
SA - Sud America 369
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 4.628
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.200
RU - Federazione Russa 903
CN - Cina 436
SG - Singapore 402
BR - Brasile 304
IT - Italia 232
SE - Svezia 203
VN - Vietnam 175
HK - Hong Kong 144
DE - Germania 88
FR - Francia 61
IN - India 39
FI - Finlandia 37
CA - Canada 36
GB - Regno Unito 35
PL - Polonia 24
AR - Argentina 23
MX - Messico 21
EC - Ecuador 19
ZA - Sudafrica 19
NL - Olanda 17
JP - Giappone 16
ES - Italia 14
BD - Bangladesh 13
TR - Turchia 12
AT - Austria 10
IE - Irlanda 10
IQ - Iraq 9
CO - Colombia 7
ID - Indonesia 7
LT - Lituania 7
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
MA - Marocco 5
PH - Filippine 5
UA - Ucraina 5
CL - Cile 4
PK - Pakistan 4
SA - Arabia Saudita 4
AU - Australia 3
CM - Camerun 3
EG - Egitto 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
A1 - Anonimo 2
BE - Belgio 2
BH - Bahrain 2
DZ - Algeria 2
KR - Corea 2
MY - Malesia 2
RS - Serbia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
VE - Venezuela 1
Totale 4.628
Salva come PNG Salva come JPEG
Città #
Dallas 279
Ashburn 208
Singapore 208
Moscow 201
Hong Kong 142
Milan 110
San Jose 97
Beijing 91
Shanghai 88
Ho Chi Minh City 75
New York 55
Hefei 52
Los Angeles 43
Lauterbourg 42
Princeton 39
Lawrence 38
São Paulo 35
Hanoi 28
Helsinki 26
Munich 26
Brescia 22
Rome 22
Warsaw 19
Santa Clara 17
Falkenstein 15
Nuremberg 15
Orem 15
Stockholm 15
Chennai 14
Denver 14
Johannesburg 14
Montreal 14
Tokyo 14
Atlanta 13
Council Bluffs 12
Haiphong 12
Cesano Boscone 11
The Dalles 11
Dublin 10
Frankfurt am Main 10
Amsterdam 9
Boston 9
Brooklyn 9
Poplar 9
Belo Horizonte 8
Guangzhou 8
Porto Alegre 8
Toronto 8
Turin 8
Bologna 7
Rio de Janeiro 7
Vienna 7
Guayaquil 6
Houston 6
Lappeenranta 6
London 6
Washington 6
Boardman 5
Chicago 5
Columbus 5
Manaus 5
Salvador 5
Shenzhen 5
Tashkent 5
Amman 4
Ancona 4
Ankara 4
Barnet 4
Campinas 4
Caxias do Sul 4
Curitiba 4
Florianópolis 4
Hải Dương 4
Manchester 4
Mexico City 4
New Delhi 4
Phoenix 4
Pune 4
Quito 4
Riyadh 4
San Francisco 4
Sorocaba 4
South San Francisco 4
Tianjin 4
Turku 4
Antakya 3
Baghdad 3
Bergamo 3
Biên Hòa 3
Bogotá 3
Brasília 3
Busto Arsizio 3
Bắc Ninh 3
Calgary 3
Changsha 3
Charlotte 3
City of London 3
Erbil 3
Guarulhos 3
Hangzhou 3
Totale 2.463
Salva come PNG Salva come JPEG
Nome #
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 177
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 159
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 131
The interferon landscape along the respiratory tract impacts the severity of COVID-19 128
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 127
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 127
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 125
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 121
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 120
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 119
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 119
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 118
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 115
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 101
Bacteriophages and Their Immunological Applications against Infectious Threats 100
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 97
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 97
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 96
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 96
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 95
The initial interplay between HIV and mucosal innate immunity 95
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 93
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 91
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 91
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 91
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 90
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 86
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 85
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 85
Evaluation of synergistic interactions of anti-HCV/E2 monoclonal antibodies 84
Editorial: Viral escape of mucosal immunity in sexually transmitted diseases 83
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 83
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 82
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 81
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 80
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 79
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 78
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 78
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 77
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 77
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 75
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 73
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 73
Role and potential therapeutic use of antibodies against herpetic infections 69
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 68
Viral Respiratory Pathogens and Lung Injury 68
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 62
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 57
Phage Therapy: An Alternative to Antibiotics 48
Next Generation Vaccines for Infectious Diseases 46
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 45
Tracking remyelination in a model of multiple sclerosis: Visual evoked potentials reveal therapeutic effect from brain stimulation and exercise 44
An Exploratory Survey on the Use of Anal Cytology as a Tool for Anal Cancer Screening in Italy 7
Long-Term Stability Bio-Reconfigurable Differential Impedance Electronic Platform for Virus Diagnostic 5
null 1
Totale 4.798
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.974
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 3 0 0
2021/202284 6 3 10 10 13 7 9 2 2 9 0 13
2022/2023356 89 78 49 7 3 41 33 30 15 2 8 1
2023/2024315 1 20 42 62 19 62 9 25 13 8 18 36
2024/2025892 81 20 13 35 33 94 158 170 90 63 58 77
2025/20263.083 233 279 373 423 305 96 259 229 779 107 0 0
Totale 4.798